Your browser doesn't support javascript.
loading
Application of mTORC1 Inhibitors for Tissue-Agnostic Management of Standard-Therapy-Refractory Solid Tumors.
Taghizadeh, Hossein; Maj-Hes, Agnieszka; Prager, Gerald W; Müllauer, Leonhard; Mader, Robert M.
Affiliation
  • Taghizadeh H; Department of Medicine I, Medical University of Vienna, 1090 Vienna, Austria.
  • Maj-Hes A; Comprehensive Cancer Center Vienna, 1090 Vienna, Austria.
  • Prager GW; Department of Medicine I, University Hospital St. Poelten, Karl Landsteiner University of Health Sciences, 3100 St. Poelten, Austria.
  • Müllauer L; Department of Medicine I, Medical University of Vienna, 1090 Vienna, Austria.
  • Mader RM; Comprehensive Cancer Center Vienna, 1090 Vienna, Austria.
Cancers (Basel) ; 14(8)2022 Apr 12.
Article in En | MEDLINE | ID: mdl-35454843
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Guideline Language: En Journal: Cancers (Basel) Year: 2022 Type: Article Affiliation country: Austria
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Guideline Language: En Journal: Cancers (Basel) Year: 2022 Type: Article Affiliation country: Austria